The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema
Author:
Publisher
BMJ
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference21 articles.
1. Cost of hospital prescribing rose 15% in a year owing to new rheumatoid arthritis and cancer drugs;Hawkes;BMJ,2014
2. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2010
3. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results;Elman;Ophthalmology,2012
4. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE Phase III clinical trials;Domalpally;Ophthalmology,2015
5. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results;Elman;Ophthalmology,2015
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative efficacy and safety of Faricimab and other anti-VEGF therapy for age-related macular degeneration and diabetic macular edema: A systematic review and meta-analysis of randomized clinical trials;Medicine;2023-12-15
2. Impact of Anti-VEGF Treatment for Diabetic Macular Oedema on Progression to Proliferative Diabetic Retinopathy: Data-driven Insights from a Multicentre Study;2023-11-12
3. From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema;Progress in Retinal and Eye Research;2023-11
4. Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study;Acta Ophthalmologica;2023-10-24
5. A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment;Frontiers in Endocrinology;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3